STAT

‘We are increasingly exposed’: New studies show how easy it is to identify people using genetic databases

Even if your genetic information isn't linked to your name and address, it might not be as anonymous as you think. Two new studies show just how easy it is…
A San Francisco Police Department wanted bulletin and copies of letters sent to the San Francisco Chronicle by a man who called himself Zodiac. Detectives in Northern California are trying to get a DNA profile on the Zodiac Killer to track him down using the same family-tree tracing technology investigators used in the Golden State Killer case.

In recent months, consumer genealogy websites have unleashed a revolution in forensics, allowing law enforcement to use family trees to track down the notorious Golden State Killer in California and solve other cold cases across the country. But while the technique has put alleged killers behind bars, it has also raised questions about the implications for genetic privacy.

According to a pair of studies published Thursday, your genetic privacy may have already eroded even further than previously realized.

In an analysis , researchers used a database run by the genealogy company MyHeritage to look at the genetic

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About GLP-1 Spending, Biosimilar Patient Costs, And More
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they're set to cost the U.S. health care system and the federal government still more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks